放射治疗的调试和收费 - - 我们如何提供先进的,创新的,个性化的放射治疗?
I Powell-Brown1, D Hutton2, N Thorp3
1NW Radiotherapy Specialised Services Clinical Network.
The British journal of radiology
|October 22, 2025
概括
目前英格兰的放射治疗费用由于更新不足,阻碍了患者获得先进治疗的机会. 修订关税可以推动创新,并改善公平获得现代放射治疗服务的机会.
科学领域:
- 在瘤学瘤学.
- 卫生经济学 卫生经济学
- 卫生政策 卫生政策
背景情况:
- 放射治疗实践随着人工智能 (AI) 等新技术的发展而进步.
- 英国现有的放射治疗费用并没有跟上临床进展的步伐.
- 这种停滞限制了患者获得创新治疗和公平护理的机会.
研究的目的:
- 探索英国目前放射治疗资金的局限性.
- 为更新放射治疗价格结构提出建议.
- 确保放射治疗提供者获得创新和以价值为基础的护理的支持.
主要方法:
- 对目前放射治疗费用限制的分析.
- 审查当代放射治疗实践和技术进步.
- 探索委托和资金结构的潜在改革.
主要成果:
- 放射治疗费率缺乏发展是采用新技术的障碍.
- 患者不公平地获得先进的放射疗法治疗是一个重大问题.
- 将委托转移到综合护理委员会 (ICB) 提供了一个改革机会.
结论:
- 更新放射治疗价格对于推动创新和确保公平获取至关重要.
- 改革委托和关税结构可以更好地使放射治疗服务与当前实践保持一致.
- 建议侧重于支持提供者提供生产性,创新性和基于价值的放射治疗.
更多相关视频
相关概念视频
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Combination Therapies and Personalized Medicine
5.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.9K
Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K


